Quest Diagnostics Incorporated (DGX)
Cash ratio
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and cash equivalents | US$ in thousands | 549,000 | 764,000 | 271,000 | 474,000 | 686,000 | 143,000 | 126,000 | 175,000 | 315,000 | 700,000 | 790,000 | 712,000 | 872,000 | 987,000 | 560,000 | 1,230,000 | 1,158,000 | 1,605,000 | 988,000 | 342,000 |
| Short-term investments | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | 28,000 | 44,000 | 124,000 | 111,000 | — | 521,000 | 480,000 | — | — |
| Total current liabilities | US$ in thousands | 2,169,000 | 2,092,000 | 2,012,000 | 2,298,000 | 1,815,000 | 1,618,000 | 1,875,000 | 1,355,000 | 1,551,000 | 1,602,000 | 1,577,000 | 1,700,000 | 1,753,000 | 1,759,000 | 1,551,000 | 1,707,000 | 1,776,000 | 2,389,000 | 1,843,000 | 1,129,000 |
| Cash ratio | 0.25 | 0.37 | 0.13 | 0.21 | 0.38 | 0.09 | 0.07 | 0.13 | 0.20 | 0.44 | 0.50 | 0.44 | 0.52 | 0.63 | 0.43 | 0.72 | 0.95 | 0.87 | 0.54 | 0.30 |
December 31, 2024 calculation
Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($549,000K
+ $—K)
÷ $2,169,000K
= 0.25
The cash ratio of Quest Diagnostics Incorporated has fluctuated over the period from March 31, 2020, to December 31, 2024. The cash ratio measures the proportion of a company's current assets held in cash to cover its current liabilities. The trend for Quest Diagnostics indicates that the company had a relatively low cash ratio in the range of 0.07 to 0.95 during this period.
The cash ratio reached its peak at 0.95 on December 31, 2020, indicating that the company had high levels of cash compared to its current liabilities at that point. However, the cash ratio decreased in the following periods, dropping to 0.07 on June 30, 2023, which suggests a lower ability to cover short-term obligations with available cash.
Overall, the fluctuating trend in Quest Diagnostics' cash ratio implies varying levels of liquidity over the analyzed period. It is essential for the company to manage its cash holdings effectively to ensure it can meet its short-term financial obligations in a sustainable manner.
Peer comparison
Dec 31, 2024